These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
798 related articles for article (PubMed ID: 19036441)
21. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Xu HB; Li L; Liu GQ Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169 [TBL] [Abstract][Full Text] [Related]
22. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid. Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038 [TBL] [Abstract][Full Text] [Related]
23. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Pichler A; Zelcer N; Prior JL; Kuil AJ; Piwnica-Worms D Clin Cancer Res; 2005 Jun; 11(12):4487-94. PubMed ID: 15958634 [TBL] [Abstract][Full Text] [Related]
24. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Arora A; Seth K; Kalra N; Shukla Y Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137 [TBL] [Abstract][Full Text] [Related]
26. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line. Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795 [TBL] [Abstract][Full Text] [Related]
27. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells. Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047 [TBL] [Abstract][Full Text] [Related]
28. [Reversal of multidrug resistance of K562/A02 cell line by mdr1 and GSTpi gene silence]. Gu JW; Zhang T; Chen BB; Lu Y; Lin GW Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):719-22. PubMed ID: 16620573 [TBL] [Abstract][Full Text] [Related]
29. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model. Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770 [TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides. Cucco C; Calabretta B Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118 [TBL] [Abstract][Full Text] [Related]
31. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells. Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489 [TBL] [Abstract][Full Text] [Related]
32. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol. Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716 [TBL] [Abstract][Full Text] [Related]
33. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides. Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384 [TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of RNA helicase A by DNA-dependent protein kinase is indispensable for expression of the MDR1 gene product P-glycoprotein in multidrug-resistant human leukemia cells. Zhong X; Safa AR Biochemistry; 2007 May; 46(19):5766-75. PubMed ID: 17441731 [TBL] [Abstract][Full Text] [Related]
35. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608 [TBL] [Abstract][Full Text] [Related]
36. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells. Peng Z; Xiao Z; Wang Y; Liu P; Cai Y; Lu S; Feng W; Han ZC Cancer Gene Ther; 2004 Nov; 11(11):707-12. PubMed ID: 15375375 [TBL] [Abstract][Full Text] [Related]
37. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists. Fu J; Chen Z; Cen J; Ruan C Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252 [TBL] [Abstract][Full Text] [Related]
39. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells. Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007 [TBL] [Abstract][Full Text] [Related]
40. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter. Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]